SOCIETY FOR IMMUNOTHERAPY OF CANCER INC

EIN: 391554806 501(c)(3)

MILWAUKEE, WI

Total Revenue
$15,211,563
Total Expenses
$15,284,371
Total Assets
$22,459,068
Net Assets
$21,004,850
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1986
Legal Domicile
WI
Principal Officer
LEISHA EMENS MD PHD
Phone
4142712456
Tax Period
2023-01-01 to 2023-12-31

SOCIETY FOR IMMUNOTHERAPY OF CANCER INC, founded in 1986, is a mid-sized nonprofit that reported $15.2M in total revenue in fiscal year 2023. Revenue decreased 12% compared to the prior year.

Mission

TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $3,448,837
Program Service Revenue $11,184,715
Investment Income $366,609
Other Revenue $211,402
TOTAL REVENUE $15,211,563

Expense Breakdown

Grants Paid $750,180
Salaries & Benefits $14,750
Fundraising Expenses $79,570
Program Expenses $13,368,325
Other Expenses $14,519,441
TOTAL EXPENSES $15,284,371

Year-over-Year Comparison

2023 2022 Change
Revenue $15,211,563 $17,242,766 -0.1%
Expenses $15,284,371 $14,244,820 +0.1%
Net Income $-72,808 $2,997,946 -1.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
13
Employees
N/A
Volunteers
36

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$750
Total Directors
13
$14,750
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LEISHA EMENS MD PHD PRESIDENT 5.00
Officer Director
$750 $0 $750
JAMES GULLEY MD PHD VICE PRESIDENT 5.00
Officer Director
$0 $0 $0
JEDD WOLCHOK MD PHD SECR/TREASURER 5.00
Officer Director
$0 $0 $0
PATRICK HWU MD IMM. PAST PRES. 5.00
Officer Director
$0 $0 $0
CHRISTIAN CAPITINI MD DIRECTOR 1.00
Director
$5,000 $0 $5,000
ADEKUNLE ODUNSI MD PHD FRCOG FACO DIRECTOR 1.00
Director
$2,500 $0 $2,500
ANN SILK MD MS DIRECTOR 1.00
Director
$3,000 $0 $3,000
JULIE BRAHMER MD DIRECTOR 1.00
Director
$500 $0 $500
JENNIFER GUERRIERO PHD DIRECTOR 1.00
Director
$1,000 $0 $1,000
JENNIFER WARGO MD MMSC DIRECTOR 1.00
Director
$2,000 $0 $2,000
JASON LUKE MD PHD DIRECTOR 1.00
Director
$0 $0 $0
SARAH WARREN PHD DIRECTOR 1.00
Director
$0 $0 $0
TULIA BRUNO PHD DIRECTOR 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $15,211,563 $15,284,371 $22,459,068 $-72,808
2022 $17,242,766 $14,244,820 $24,306,761 $2,997,946
2021 $14,185,558 $11,322,716 $21,926,685 $2,862,842
2020 $6,573,551 $8,071,441 $16,830,653 $-1,497,890
2019 $13,947,573 $11,066,744 $17,497,919 $2,880,829
2018 $13,622,016 $11,381,850 $14,883,434 $2,240,166
Explore More Nonprofits
Top 100 Nonprofits in Wisconsin Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare SOCIETY FOR IMMUNOTHERAPY OF CANCER INC with other nonprofits in Wisconsin and across the country.